Filter Results:
(5,080)
Show Results For
- All HBS Web
(5,080)
- People (16)
- News (1,936)
- Research (2,541)
- Events (3)
- Multimedia (224)
- Faculty Publications (1,936)
Show Results For
- All HBS Web
(5,080)
- People (16)
- News (1,936)
- Research (2,541)
- Events (3)
- Multimedia (224)
- Faculty Publications (1,936)
- November 2016
- Case
QuintilesIMS: Biosimilar Marketing in England
By: John A. Quelch and Emily C. Boudreau
QuintilesIMS was a leading healthcare consulting firm best known for its data and information offerings as well as its market research and management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical... View Details
Keywords: Health; Pharmaceutical Industry; Biotech; Marketing; Health Care and Treatment; Biotechnology Industry; England
Quelch, John A., and Emily C. Boudreau. "QuintilesIMS: Biosimilar Marketing in England." Harvard Business School Case 517-054, November 2016.
- 23 Apr 2014
- News
Are Electronic Cigarettes a Public Good or Health Hazard?
- 01 Sep 2007
- News
‘Redefining Health Care’: Medical Homes or Archipelagos to Navigate?
- 07 Feb 2007
- News
A Failing Transparency of Design Principles in Health Care?
- 16 May 2017
- Blog Post
Making the Move into Digital Health and Software Engineering
We caught up with Andrea Coravos (HBS 2017) after a Q&A she did with the MBA Voices blog during her second year at HBS. Coravos reflects on her time at HBS and how she transitioned into digital health and engineering following a... View Details
- September 2023
- Teaching Note
Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment
Teaching Note for HBS Case No. 304-009. The case is part of the first module of the Innovating in Health Care course. Its purpose is to demonstrate how to evaluate the “do good” and do well” potential of a health care innovation. View Details
- Research Summary
Clinical Trials as a setting for Health Policy and Management Research
The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details
- 04 Jun 2009
- News
NEJM Explores The Value-Based System Approach To Health Reform
- March 2010
- Teaching Note
Narayana Hrudayalaya Heart Hospital: Cardiac Care for the Poor (TN)
By: Tarun Khanna and V. Kasturi Rangan
Teaching Note for [505078]. View Details
- 07 Jan 2025
- Blog Post
Revolutionizing Wellness: Kate Twist (MBA 2008) Shapes the Future of Consumer Health Brands
$100mm to expand nationally, and has partnered with major retailers, developed products, launched campaigns, and digitized consumer experiences. With a passion for high-growth businesses and a commitment to helping underrepresented founders, Twist is re-imagining the... View Details
- February 2014
- Teaching Note
Community Health Workers in Zambia: Incentive Design and Management
By: Nava Ashraf and Kristin Johnson
Keywords: Developing Countries and Economies; Training; Health Care and Treatment; Compensation and Benefits; Recruitment; Selection and Staffing; Mission and Purpose; Non-Governmental Organizations; Motivation and Incentives; Health Industry; Zambia
Ashraf, Nava, and Kristin Johnson. "Community Health Workers in Zambia: Incentive Design and Management." Harvard Business School Teaching Note 914-024, February 2014. (Request a courtesy copy.)
- May 2017
- Teaching Plan
Neurotrack and the Alzheimer's Puzzle
By: Richard G. Hamermesh and Carin-Isabel Knoop
Teaching Note for HBS No. 816-072. View Details
- September 2014 (Revised February 2015)
- Case
Pfizer and AstraZeneca: Marketing an Acquisition (A)
By: John A. Quelch and James Weber
In 2014, Pfizer proposed a friendly acquisition of AstraZeneca, but the AstraZeneca board resisted over price and strategy concerns. Was this good for pharmaceutical consumers? Pfizer, like pharmaceutical companies in general, faced difficulties in growing sales due to... View Details
Keywords: Health Care Policy; Mergers And Acquisitions; Marketing; Government Relations; Crisis Management; Decision Making; Growth and Development; Management; Markets; Strategy; Pharmaceutical Industry; United Kingdom; United States
Quelch, John A., and James Weber. "Pfizer and AstraZeneca: Marketing an Acquisition (A)." Harvard Business School Case 515-007, September 2014. (Revised February 2015.)
- Article
Narrow Networks on the Health Insurance Marketplaces: Prevalence, Pricing, and the Cost of Network Breadth
By: Leemore S. Dafny, Igal Hendel, Victoria Marone and Christopher Ody
Anecdotal reports and systematic research highlight the prevalence of narrow-network plans on the Affordable Care Act’s health insurance Marketplaces. At the same time, Marketplace premiums in the period 2014–2016 were much lower than projected by the Congressional... View Details
Dafny, Leemore S., Igal Hendel, Victoria Marone, and Christopher Ody. "Narrow Networks on the Health Insurance Marketplaces: Prevalence, Pricing, and the Cost of Network Breadth." Health Affairs 36, no. 9 (September 2017).
- December 2013 (Revised May 2021)
- Case
Paul Levy: Confronting a 'Corporate Campaign' (A)
Hospital CEO Paul Levy confronts an SEIU unionization drive via a "corporate campaign" aimed at undercutting the hospital's relationships with key internal and external constituencies. Having shepherded one of Boston's top teaching hospitals much of the way through a... View Details
Keywords: Dispute Resolution; Corporate Campaign; Negotiating Campaign; Bargaining; Health Care; Hospitals; Unions; Health Care and Treatment; Negotiation; Strategy; Negotiation Process; Labor Unions; Health Industry; Boston
Sebenius, James K. "Paul Levy: Confronting a 'Corporate Campaign' (A)." Harvard Business School Case 914-020, December 2013. (Revised May 2021.)
- 2012
- Report
Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health
By: Mark R. Kramer, Kyle Peterson, Matthew Rehrig, Mike Stamp and Samuel Kim
Examples of how pharmaceutical and medical companies are addressing unmet health needs in low- and middle- income economies, creating shared value by providing products and services that tackle global health problems. View Details
Keywords: Shared Value; Low- And Middle-income Economies; Health Care and Treatment; Global Range; Pharmaceutical Industry; Medical Devices and Supplies Industry
Kramer, Mark R., Kyle Peterson, Matthew Rehrig, Mike Stamp, and Samuel Kim. "Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health." Report, FSG, 2012.
- 15 Feb 2022
- Blog Post
Health Is Wealth | The Path To Creating A Venture
opportunities to leverage technology to help people experience their healthcare in a better way. Driven by her own personal health experiences in where she constantly used a guess and check methodology to improve her health, she sought to... View Details
- 23 Jun 2016
- News